THU 02 JUL 2026 · GMT EDITION A WHITESTONE INTELLIGENCE PUBLICATION
MARKETS · CYBER · MEMOS · MODELS
DAILY ISSUES26 MAY27 MAY28 MAY29 MAY30 MAY31 MAY01 JUN02 JUN03 JUN04 JUN05 JUN06 JUN07 JUN08 JUN09 JUN10 JUN11 JUN12 JUN13 JUN14 JUN15 JUN16 JUN17 JUN18 JUN19 JUN21 JUN22 JUN23 JUN24 JUN25 JUN26 JUN27 JUN28 JUN29 JUN30 JUN01 JUN02 JUNALL ›
FRONT PAGE / MEMOS / MEM-2026-06-23-F1
MEMOS · sec filings · 2026-06-23SCOOP 63

FTC Files Amicus Brief in Antitrust Case Alleging Johnson & Johnson Monopoly Conduct

The Federal Trade Commission filed an amicus brief in an antitrust case in which drug manufacturer Johnson & Johnson is alleged to have illegally maintained a monopoly through anticompetitive conduct, per the FTC's June .

·FILED ISSUE 2026-06-23·1 MIN READ·RE-VERIFIED 2026-07-02 UTC·✓ RE-VERIFIED 2026-07-02

At a glance

  • The FTC filed an amicus brief in an antitrust case involving Johnson & Johnson, per the agency's June 23, 2026 release.
  • The underlying case alleges Johnson & Johnson illegally maintained a monopoly through anticompetitive conduct, per the FTC.

VERDICT — CONFIRMED

pipeline-backfill confidence · primary + corroborating sources verified · re-verified 2026-07-02 UTC
FTC Files Amicus Brief in Antitrust Case Alleging Johnson & Johnson Monopoly Conduct
Photo: G. Edward Johnson · via Wikimedia Commons · CC BY 4.0

The Federal Trade Commission filed an amicus brief in an antitrust case in which drug manufacturer Johnson & Johnson is alleged to have illegally maintained a monopoly through anticompetitive conduct, per the FTC's June 23 press release. The agency framed the filing as an effort to protect consumers from pharmaceutical monopolies, per the release. The allegations against Johnson & Johnson are claims in litigation, not adjudicated findings.

Key facts on file

  • The FTC filed an amicus brief in an antitrust case involving Johnson & Johnson, per the agency's June 23, 2026 release.
  • The underlying case alleges Johnson & Johnson illegally maintained a monopoly through anticompetitive conduct, per the FTC.

OFFICIAL RECORD

FTC — Press Releases
— (2026-06-23) · fetched at filing · archived at publication
Filed underFTCANTITRUST

Sources · two-source rule

PRIMARY · DOCFTC — Press Releases— (2026-06-23)
Share
Filed by the Memos desk · verified by the verification desk · re-verified 2026-07-02 · Our standards: the two-source rule ›
CITE THIS FILE — The Dossier Wire · mem-2026-06-23-f1 · filed 2026-06-23 · https://thedwire.com/wire/mem-2026-06-23-f1-ftc-files-amicus-brief-in-antitrust-case-alleging-johnson.html · Primary and corroborating sources listed above; archived at publication. Republishing & licensing: hello@thedwire.com.
More from Memos FULL DESK ›
Memos desk illustration
Generated desk illustration · not a photograph
MEMOS · SCOOP 58

CFTC Sues Kentucky to Block State Enforcement Against Federally Registered Contract Markets

The Commodity Futures Trading Commission filed a lawsuit against Kentucky to block the state's efforts to shut down CFTC-registered contract markets using state laws, per the commission's June 23 press release. Per the release, Kentucky had filed civil enforcement actions in state court against CFTC-regulated designated contract markets s

✓ verifiednewSOURCE ↗
READ THE FILE ›
Memos desk illustration
Generated desk illustration · not a photograph
MEMOS · SCOOP 63

FTC Finalizes Consent Order Requiring Rollins to Stop Enforcing Noncompetes Against More Than 18,000 Employees

The Federal Trade Commission finalized a consent order requiring Rollins Inc. — described by the agency as one of the largest pest-control companies in the United States — to stop enforcing noncompete agreements against more than 18,000 employees nationwide, per the FTC's June 22 press release.

✓ verifiednewSOURCE ↗
READ THE FILE ›
Memos desk illustration
Generated desk illustration · not a photograph
MEMOS · SCOOP 55

U.S. Launches Trade Investigation Into German Plan to Cut Pharmaceutical Spending

The United States has launched a trade investigation into a German plan to cut spending on pharmaceuticals, a move that could result in fresh tariffs, per The Wall Street Journal's June 19 report. Per the Journal, the investigation follows Berlin's announcement that it would require drugmakers to offer bigger discounts on medicines.

✓ verifiednewSOURCE ↗
READ THE FILE ›

The morning wire in your inbox — every brief, primary sources linked, no noise.

Free tier. The Wire — continuous desk briefs · Records archive · Bureau alerts.

Stored to the wire's subscriber list. No spam, unsubscribe any time.